Stock data
Agios Pharmaceuticals, Inc. (AGIO)
Agios Pharmaceuticals, Inc. (AGIO) reported revenue of US$54.03M and net income of -US$412.78M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$54.03M | — | -US$472.13M | -US$412.78M | — |
| 2024 | US$36.50M | — | -US$425.74M | US$673.73M | — |
| 2023 | US$26.82M | — | -US$391.49M | -US$352.09M | — |
| 2022 | US$14.24M | — | -US$389.05M | -US$231.80M | — |
| 2021 | US$0.00M | — | -US$378.42M | US$1.60B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$44.74M | -US$100.70M | — |
| 2026-03-31 | US$20.75M | -US$99.11M | — |
| 2025-12-31 | US$19.97M | -US$108.04M | — |
| 2025-09-30 | US$12.88M | -US$103.43M | — |
| 2025-06-30 | US$12.46M | -US$112.02M | — |
| 2025-03-31 | US$8.73M | -US$89.29M | — |
| 2024-12-31 | US$10.73M | -US$96.52M | — |
| 2024-09-30 | US$8.96M | US$947.91M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.